Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with alzheimer-like Tau pathology

Human Molecular Genetics

Volumn 24, Issue 21, 2015, Pages 5965-5976

  Burlot, Marie Anne ^a,b,c   Braudeau, Jérôme ^a,b   Michaelsen Preusse, Kristin ^d,e   Potier, Brigitte ^f   Ayciriex, Sophie ^g   Varin, Jennifer ^c   Gautier, Benoit ^a,b   Djelti, Fathia ^a,b,c   Audrain, Mickael ^a,b,c   Dauphinot, Luce ^h   Fernandez Gomez, Francisco Jose ^i,j   Caillierez, Raphaëlle ^i,j   Laprévote, Olivier ^g   Bièche, Ivan ^c   Auzeil, Nicolas ^g   Potier, Marie Claude ^h   Dutar, Patrick ^f   Korte, Martin ^d,e   Buée, Luc ^i,j,k   Blum, David ^i,j,k   Cartier, Nathalie ^a,b   more..

^a Molecular Imaging Research Center   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^f CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^g EA 4463   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ UNIV LILLE   (France)

^j JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^k LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

24 HYDROXYCHOLESTEROL; AMYLOID PROTEIN; CHOLESTEROL; CHOLESTEROL 24 HYDROXYLASE; OXYGENASE; PARVOVIRUS VECTOR; TAU PROTEIN; UNCLASSIFIED DRUG; 24-HYDROXYCHOLESTEROL; CHOLESTEROL 24-HYDROXYLASE; CHOLESTEROL DERIVATIVE; STEROID MONOOXYGENASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYP46A1 GENE; DENDRITIC SPINE; GENE; GENE EXPRESSION; GLIOSIS; HIPPOCAMPAL CA1 REGION; LONG TERM DEPRESSION; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; TAUOPATHY; VIRAL GENE DELIVERY SYSTEM; ANIMAL; DISEASE MODEL; ENZYMOLOGY; GENETICS; HIPPOCAMPUS; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; GLIOSIS; HIPPOCAMPUS; HUMANS; HYDROXYCHOLESTEROLS; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; STEROID HYDROXYLASES; TAU PROTEINS; TAUOPATHIES;

EID: 84949256198     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv268     Document Type: Article

References (66)

1. Querfurth, H.W. and LaFerla, F.M. (2010) Alzheimer's disease. N. Engl. J. Med., 362, 329-344.
2. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95-130.
3. Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E. et al. (2008) Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics, 5, 207-224.
4. Grober, E., Dickson, D., Sliwinski, M.J., Buschke, H., Katz, M., Crystal, H. and Lipton, R.B. (1999) Memory and mental status correlates of modified Braak staging. Neurobiol. Aging, 20, 573-579.
5. Duyckaerts, C., Bennecib, M., Grignon, Y., Uchihara, T., He, Y., Piette, F. and Hauw, J.J. (1997) Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol. Aging, 18, 267-273.
6. Delacourte, A., David, J.P., Sergeant, N., Buee, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F. et al. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology, 52, 1158-1165.
7. Giannakopoulos, P., Herrmann, F.R., Bussiere, T., Bouras, C., Kovari, E., Perl, D.P., Morrison, J.H., Gold, G. and Hof, P.R. (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology, 60, 1495-1500.
8. Burnouf, S., Martire, A., Derisbourg, M., Laurent, C., Belarbi, K., Leboucher, A., Fernandez-Gomez, F.J., Troquier, L., Eddarkaoui, S., Grosjean, M.E. et al. (2013) NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Aging Cell, 12, 11-23.
9. Hoover, B.R., Reed, M.N., Su, J., Penrod, R.D., Kotilinek, L.A., Grant, M.K., Pitstick, R., Carlson, G.A., Lanier, L.M., Yuan, L.L. et al. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron, 68, 1067-1081.
10. Polydoro, M., Acker, C.M., Duff, K., Castillo, P.E. and Davies, P. (2009) Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J. Neurosci., 29, 10741-10749.
11. Le Freche, H., Brouillette, J., Fernandez-Gomez, F.J., Patin, P., Caillierez, R., Zommer, N., Sergeant, N., Buee-Scherrer, V., Lebuffe, G., Blum, D. et al. (2012) Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology, 116, 779-787.
12. Chaalal, A., Poirier, R., Blum, D., Gillet, B., Le Blanc, P., Basquin, M., Buee, L., Laroche, S. and Enderlin, V. (2014) PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments. Hippocampus, in press.
13. Van der Jeugd, A., Ahmed, T., Burnouf, S., Belarbi, K., Hamdame, M., Grosjean, M.E., Humez, S., Balschun, D., Blum, D., Buee, L. et al. (2011) Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol. Learn. Mem., 95, 296-304.
14. Puglielli, L., Tanzi, R.E. and Kovacs, D.M. (2003) Alzheimer's disease: the cholesterol connection. Nature Neurosci., 6, 345-351.
15. Evans, R.M., Hui, S., Perkins, A., Lahiri, D.K., Poirier, J. and Farlow, M.R. (2004) Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology, 62, 1869-1871.
16. Bu, G. (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nature Rev. Neurosci., 10, 333-344.
17. Kim, J., Basak, J.M. and Holtzman, D.M. (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron, 63, 287-303.
18. Bjorkhem, I. (2006) Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med., 260, 493-508.
19. Lund, E.G., Guileyardo, J.M. and Russell, D.W. (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U.S.A., 96, 7238-7243.
20. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., Troncoso, J.C. and Mattson, M.P. (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 101, 2070-2075.
21. Lazar, A.N., Bich, C., Panchal, M., Desbenoit, N., Petit, V.W., Touboul, D., Dauphinot, L., Marquer, C., Laprevote, O., Brunelle, A. et al. (2013) Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients. Acta Neuropathol., 125, 133-144.
22. Distl, R., Meske, V. and Ohm, T.G. (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol., 101, 547-554.
23. Bretillon, L., Siden, A., Wahlund, L.O., Lutjohann, D., Minthon, L., Crisby, M., Hillert, J., Groth, C.G., Diczfalusy, U. and Bjorkhem, I. (2000) Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci. Lett., 293, 87-90.
24. Kolsch, H., Heun, R., Kerksiek, A., Bergmann, K.V., Maier, W. and Lutjohann, D. (2004) Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci. Lett., 368, 303-308.
25. Papassotiropoulos, A., Lutjohann, D., Bagli, M., Locatelli, S., Jessen, F., Rao, M.L., Maier, W., Bjorkhem, I., von Bergmann, K. and Heun, R. (2000) Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport, 11, 1959-1962.
26. Solomon, A., Leoni, V., Kivipelto, M., Besga, A., Oksengard, A.R., Julin, P., Svensson, L., Wahlund, L.O., Andreasen, N., Winblad, B. et al. (2009) Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci. Lett., 462, 89-93.
27. Leoni, V., Solomon, A., Lovgren-Sandblom, A., Minthon, L., Blennow, K., Hansson, O., Wahlund, L.O., Kivipelto, M. and Bjorkhem, I. (2013) Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. J. Alzheimers Dis., 36, 739-747.
28. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buee, L. and Brion, J.P. (2007) Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am. J. Pathol., 171, 976-992.
29. Hudry, E., Van Dam, D., Kulik, W., De Deyn, P.P., Stet, F.S., Ahouansou, O., Benraiss, A., Delacourte, A., Bougneres, P., Aubourg, P. et al. (2010) Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol. Ther., 18, 44-53.
30. Laurent, C., Burnouf, S., Ferry, B., Batalha, V.L., Coelho, J.E., Baqi, Y., Malik, E., Mariciniak, E., Parrot, S., Van der Jeugd, A. et al. (2014) A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol. Psychiatry, in press.
31. Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Muller, C.E., Buee, L. et al. (2014) Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiol. Aging, 35, 2079-2090.
32. Troquier, L., Caillierez, R., Burnouf, S., Fernandez-Gomez, F.J., Grosjean, M.E., Zommer, N., Sergeant, N., Schraen-Maschke, S., Blum, D. and Buee, L. (2012) Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr. Alzheimer Res., 9, 397-405.
33. Leboucher, A., Laurent, C., Fernandez-Gomez, F.J., Burnouf, S., Troquier, L., Eddarkaoui, S., Demeyer, D., Caillierez, R., Zommer, N., Vallez, E. et al. (2013) Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice. Diabetes, 62, 1681-1688.
34. Belarbi, K., Burnouf, S., Fernandez-Gomez, F.J., Laurent, C., Lestavel, S., Figeac, M., Sultan, A., Troquier, L., Leboucher, A., Caillierez, R. et al. (2011) Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol. Dis., 43, 486-494.
35. Kotti, T.J., Ramirez, D.M., Pfeiffer, B.E., Huber, K.M. and Russell, D.W. (2006) Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl. Acad. Sci. U.S.A., 103, 3869-3874.
36. Maioli, S., Bavner, A., Ali, Z., Heverin, M., Ismail, M.A., Puerta, E., Olin, M., Saeed, A., Shafaati, M., Parini, P. et al. (2013) Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain? PLoS One, 8, e68534.
37. Yang, S., Cacquevel, M., Saksida, L.M., Bussey, T.J., Schneider, B.L., Aebischer, P., Melani, R., Pizzorusso, T., Fawcett, J.W. and Spillantini, M.G. (2015) Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology. Exp. Neurol., 265, 48-58.
38. Brownlow, M.L., Joly-Amado, A., Azam, S., Elza, M., Selenica, M.L., Pappas, C., Small, B., Engelman, R., Gordon, M.N. and Morgan, D. (2014) Partial rescue of memory deficits induced by calorie restriction in a mouse model of tau deposition. Behav. Brain Res., 271, 79-88.
39. Blurton-Jones, M., Kitazawa, M., Martinez-Coria, H., Castello, N.A., Muller, F.J., Loring, J.F., Yamasaki, T.R., Poon, W.W., Green, K.N. and LaFerla, F.M. (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A., 106, 13594-13599.
40. Belarbi, K., Burnouf, S., Fernandez-Gomez, F.J., Desmercieres, J., Troquier, L., Brouillette, J., Tsambou, L., Grosjean, M.E., Caillierez, R., Demeyer, D. et al. (2011) Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology? Curr. Alzheimer Res., 8, 633-638.
41. Cabeza, C., Figueroa, A., Lazo, O.M., Galleguillos, C., Pissani, C., Klein, A., Gonzalez-Billault, C., Inestrosa, N.C., Alvarez, A.R., Zanlungo, S. et al. (2012) Cholinergic abnormalities, endosomal alterations and up-regulation of nerve growth factor signaling in Niemann-Pick type C disease. Mol. Neurodegener., 7, 11.
42. Suzuki, S., Numakawa, T., Shimazu, K., Koshimizu, H., Hara, T., Hatanaka, H., Mei, L., Lu, B. and Kojima, M. (2004) BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J. Cell Biol., 167, 1205-1215.
43. Paul, S.M., Doherty, J.J., Robichaud, A.J., Belfort, G.M., Chow, B.Y., Hammond, R.S., Crawford, D.C., Linsenbardt, A.J., Shu, H.J., Izumi, Y. et al. (2013) The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. J. Neurosci., 33, 17290-17300.
44. Abildayeva, K., Jansen, P.J., Hirsch-Reinshagen, V., Bloks, V.W., Bakker, A.H., Ramaekers, F.C., de Vente, J., Groen, A.K., Wellington, C.L., Kuipers, F. et al. (2006) 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem., 281, 12799-12808.
45. Sodhi, R.K. and Singh, N. (2014) Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia. Eur. J. Pharmacol., 732, 50-59.
46. Donkin, J.J., Stukas, S., Hirsch-Reinshagen, V., Namjoshi, D., Wilkinson, A., May, S., Chan, J., Fan, J., Collins, J. andWellington, C.L. (2010) ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice. J. Biol. Chem., 285, 34144-34154.
47. Fitz, N.F., Cronican, A., Pham, T., Fogg, A., Fauq, A.H., Chapman, R., Lefterov, I. and Koldamova, R. (2010) Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J. Neurosci., 30, 6862-6872.
48. Vanmierlo, T., Rutten, K., Dederen, J., Bloks, V.W., van Varkvan der Zee, L.C., Kuipers, F., Kiliaan, A., Blokland, A., Sijbrands, E.J., Steinbusch, H. et al. (2011) Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol. Aging, 32, 1262-1272.
49. Shafaati, M., Olin, M., Bavner, A., Pettersson, H., Rozell, B., Meaney, S., Parini, P. and Bjorkhem, I. (2011) Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo. J. Intern. Med., 270, 377-387.
50. Kotti, T., Head, D.D., McKenna, C.E. and Russell, D.W. (2008) Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proc. Natl. Acad. Sci. U.S.A., 105, 11394-11399.
51. Merino-Serrais, P., Benavides-Piccione, R., Blazquez-Llorca, L., Kastanauskaite, A., Rabano, A., Avila, J. and DeFelipe, J. (2013) The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease. Brain, 136, 1913-1928.
52. Xu, H., Rosler, T.W., Carlsson, T., de Andrade, A., Bruch, J., Hollerhage, M., Oertel, W.H. and Hoglinger, G.U. (2014) Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice. Neuropathol. Appl. Neurobiol., in press.
53. Alldred, M.J., Duff, K.E. and Ginsberg, S.D. (2012) Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol. Dis., 45, 751-762.
54. Fox, L.M., William, C.M., Adamowicz, D.H., Pitstick, R., Carlson, G.A., Spires-Jones, T.L. and Hyman, B.T. (2011) Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model. J. Neuropathol. Exp. Neurol., 70, 588-595.
55. Kee, N., Teixeira, C.M., Wang, A.H. and Frankland, P.W. (2007) Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nature Neurosci., 10, 355-362.
56. Jones, M.W., Errington, M.L., French, P.J., Fine, A., Bliss, T.V., Garel, S., Charnay, P., Bozon, B., Laroche, S. and Davis, S. (2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nature Neurosci., 4, 289-296.
57. Van der Jeugd, A., Blum, D., Raison, S., Eddarkaoui, S., Buee, L. and D'Hooge, R. (2013) Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia. Behav. Brain Res., 242, 34-39.
58. Schindowski, K., Bretteville, A., Leroy, K., Begard, S., Brion, J.P., Hamdane, M. and Buee, L. (2006) Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am. J. Pathol., 169, 599-616.
59. Whittington, R.A., Bretteville, A., Dickler, M.F. and Planel, E. (2013) Anesthesia and tau pathology. Prog. Neuropsychopharmacol. Biol. Psychiatry, 47, 147-155.
60. Gaudin, M., Panchal, M., Ayciriex, S., Werner, E., Brunelle, A., Touboul, D., Boursier-Neyret, C., Auzeil, N., Walther, B., Duyckaerts, C. et al. (2014) Ultra performance liquid chromatography- mass spectrometry studies of formalin-induced alterations of human brain lipidome. J. Mass Spectrom., 49, 1035-1042.
61. Ayciriex, S., Regazzetti, A., Gaudin, M., Prost, E., Dargere, D., Massicot, F., Auzeil, N. and Laprevote, O. (2012) Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model. Anal. Bioanal. Chem., 404, 3049-3059.
62. Butchbach, M.E., Tian, G., Guo, H. and Lin, C.L. (2004) Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J. Biol. Chem., 279, 34388-34396.
63. Bieche, I., Parfait, B., Le Doussal, V., Olivi, M., Rio, M.C., Lidereau, R. and Vidaud, M. (2001) Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res., 61, 1652-1658.
64. Braudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R.H., Herault, Y., Delatour, B. and Potier, M.C. (2011) Chronic treatment with a promnesiant GABA-A alpha5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a down syndrome mouse model. Adv. Pharmacol. Sci., 2011, 153218.
65. Potier, B., Billard, J.M., Riviere, S., Sinet, P.M., Denis, I., Champeil-Potokar, G., Grintal, B., Jouvenceau, A., Kollen, M. and Dutar, P. (2010) Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats. Aging Cell, 9, 722-735.
66. Michaelsen, K., Zagrebelsky, M., Berndt-Huch, J., Polack, M., Buschler, A., Sendtner, M. and Korte, M. (2010) Neurotrophin receptors TrkB.T1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons. Eur. J. Neurosci., 32, 1854-1865.